Development of Medical Countermeasures to Mitigate or Treat GI-ARS

Rxbio, Inc., Johnson City TN

Investigators

Abstract

The contracts awarded under this initiative will advance the development of candidate medical countermeasures (MCM) that can mitigate or treat gastrointestinal (GI) syndrome of the acute radiation syndrome (GI-ARS) and increase survival.